These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37424312)

  • 1. Thrombolysis for central retinal artery occlusion: An individual participant-level meta-analysis.
    Shahjouei S; Bavarsad Shahripour R; Dumitrascu OM
    Int J Stroke; 2024 Jan; 19(1):29-39. PubMed ID: 37424312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis in central retinal artery occlusion: a retrospective observational study.
    Raber FP; Gmeiner FV; Dreyhaupt J; Wolf A; Ludolph AC; Werner JU; Kassubek J; Althaus K
    J Neurol; 2023 Feb; 270(2):891-897. PubMed ID: 36305969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis.
    Schrag M; Youn T; Schindler J; Kirshner H; Greer D
    JAMA Neurol; 2015 Oct; 72(10):1148-54. PubMed ID: 26258861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intra-arterial thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis.
    Huang L; Wang Y; Zhang R
    Graefes Arch Clin Exp Ophthalmol; 2023 Jan; 261(1):103-113. PubMed ID: 35947182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of intra-arterial thrombolysis in central retinal artery occlusion.
    Ahn SJ; Kim JM; Hong JH; Woo SJ; Ahn J; Park KH; Han MK; Jung C
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7746-55. PubMed ID: 24176901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombolysis in central retinal artery occlusion using alteplase].
    Mach R; Procházka J
    Cesk Slov Oftalmol; 2008 Nov; 64(6):245-8. PubMed ID: 19110967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central retinal artery occlusion. Importance of selective intra-arterial fibrinolysis].
    Framme C; Spiegel D; Roider J; Sachs HG; Lohmann CP; Butz B; Link J; Gabel VP
    Ophthalmologe; 2001 Aug; 98(8):725-30. PubMed ID: 11552411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial thrombolysis for retinal artery occlusion: the Calgary experience.
    Pettersen JA; Hill MD; Demchuk AM; Morrish W; Hudon ME; Hu W; Wong J; Barber PA; Buchan AM
    Can J Neurol Sci; 2005 Nov; 32(4):507-11. PubMed ID: 16408583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of IV Thrombolysis in retinal artery occlusion: A multicenter retrospective cohort study.
    Baumgartner P; Kook L; Altersberger VL; Gensicke H; Ardila-Jurado E; Kägi G; Salerno A; Michel P; Gopisingh KM; Nederkoorn PJ; Scheitz JF; Nolte CH; Heldner MR; Arnold M; Cordonnier C; Della Schiava L; Hametner C; Ringleb PA; Leker RR; Jubran H; Luft AR; Engelter ST; Wegener S;
    Eur Stroke J; 2023 Dec; 8(4):966-973. PubMed ID: 37421135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis.
    Huang L; Wang Y; Zhang R
    J Neurol; 2022 Apr; 269(4):1825-1833. PubMed ID: 34625849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision!
    Dumitrascu OM; Newman NJ; Biousse V
    J Neuroophthalmol; 2020 Sep; 40(3):333-345. PubMed ID: 32739995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Fibrinolysis for Central Retinal Artery Occlusion: A Cohort Study and Updated Patient-Level Meta-Analysis.
    Mac Grory B; Nackenoff A; Poli S; Spitzer MS; Nedelmann M; Guillon B; Preterre C; Chen CS; Lee AW; Yaghi S; Stretz C; Azher I; Paddock J; Bakaeva T; Greer DM; Shulman JG; Kowalski RG; Lavin P; Mistry E; Espaillat K; Furie K; Kirshner H; Schrag M
    Stroke; 2020 Jul; 51(7):2018-2025. PubMed ID: 32568646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial.
    Chen CS; Lee AW; Campbell B; Lee T; Paine M; Fraser C; Grigg J; Markus R
    Stroke; 2011 Aug; 42(8):2229-34. PubMed ID: 21757667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Intra-Arterial Thrombolysis for Acute Central Retinal Artery Occlusion: A Meta-Analysis.
    Hu H; Zhang B; Zhao Y; Zhou H; Chen H; Yan S
    Eur Neurol; 2022; 85(3):186-194. PubMed ID: 34847561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial thrombolysis for central retinal artery occlusion: two cases report.
    Hwang G; Woo SJ; Jung C; Park KH; Hwang JM; Kwon OK
    J Korean Med Sci; 2010 Jun; 25(6):974-9. PubMed ID: 20514326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Recombinant Tissue-Type Plasminogen Activator Thrombolysis for Acute Central Retinal Artery Occlusion.
    Wang X; Liu Y; Suo Y; Qin D; Ren M; Lei R; Zhang Y; Wang Y
    J Craniofac Surg; 2021 Jan-Feb 01; 32(1):313-316. PubMed ID: 33156166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Intravenous Thrombolysis Safe and Effective in Central Retinal Artery Occlusion? A Critically Appraised Topic.
    Dumitrascu OM; Shen JF; Kurli M; Aguilar MI; Marks LA; Demaerschalk BM; Wingerchuk DM; O'Carroll CB
    Neurologist; 2017 Jul; 22(4):153-156. PubMed ID: 28644261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome after thrombolysis for acute isolated posterior cerebral artery occlusion.
    Meier N; Fischer U; Schroth G; Findling O; Brekenfeld C; El-Koussy M; De Marchis GM; Mono ML; Jung S; Gralla J; Nedeltchev K; Mattle HP; Arnold M
    Cerebrovasc Dis; 2011; 32(1):79-88. PubMed ID: 21677431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
    Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H
    Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.